Personalized mRNA cancer vaccines are showing early success in clinical trials, fueling optimism in the fight against cancer.

The FDA's approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu ...

St. Louis researchers played a vital role in clinical trials for a newly approved tool designed to protect families ahead of ...

The announcement from Merck & Co. and Moderna last month that their mRNA cancer vaccine had successfully lengthened patient ...

Australia's drive to inoculate little penguins on Phillip Island against the H5N1 bird flu virus has spurred false claims the ...

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The flu might be a relatively common illness, but it’s nothing to mess around with. The Centers for Disease Control and Prevention (CDC) estimates that in a typical year, the flu kills tens of ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling ...